Literature DB >> 1421373

Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units.

S H Boyer1, T R Bishop, O C Rogers, A N Noyes, L P Frelin, S Hobbs.   

Abstract

We have used 75% to 90% pure murine erythroid colony-forming units (CFU-E) to delineate the processes and factors underlying their maturation. These CFU-E form 32 cell colonies and are drawn from what we term generation I of a six-generation long maturation sequence (Landschulz et al, Blood 79:2749, 1992). Applying assays of 59Fe-heme biosynthesis and colony numbers as measures of maturation and analyses of DNA degradation as an index of programmed cell death, we find that (1) erythropoietin (Epo) enhances maturation throughout most of its course; (2) Epo first seems able to forestall DNA degradation when CFU-E reach generation II; (3) the processes that Epo elicits thereafter start to persist when Epo is withdrawn; (4) insulin-like growth factor I (IGF-I) also forestalls DNA breakdown, but later loses effectiveness; (5) IGF-I adds little to maturation when Epo levels are high, but when Epo levels are low, enhances it substantially; and (6) for maturation to be entirely optimal, an unidentified serum factor(s) is probably required when Epo levels are high and is certainly needed when Epo levels are like those in normal animals. Quantitatively, about 40% of optimal in vitro erythropoiesis at normal Epo levels depends on Epo alone, another 30% or less on the addition of IGF-I, and the remaining 30% or more on the addition of unidentified serum factor(s). Applied together, these three or more factors lead to two-thirds of the maximum maturation realized with saturating Epo levels. Because we also find that heme accumulated in CFU-E culture can closely approach levels in red blood cells, we suppose that our conclusions apply as well to CFU-E maturation in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1421373

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Chiral resolution of plasma amino acids reveals enantiomer-selective associations with organ functions.

Authors:  Masataka Suzuki; Ryoko Shimizu-Hirota; Masashi Mita; Kenji Hamase; Jumpei Sasabe
Journal:  Amino Acids       Date:  2022-02-28       Impact factor: 3.520

2.  Thermal injury of the skin induces G-CSF-dependent attenuation of EPO-mediated STAT signaling and erythroid differentiation arrest in mice.

Authors:  John G Noel; Benjamin J Ramser; Jose A Cancelas; Francis X McCormack; Jason C Gardner
Journal:  Exp Hematol       Date:  2017-09-01       Impact factor: 3.084

3.  Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53.

Authors:  L L Kelley; W F Green; G G Hicks; M C Bondurant; M J Koury; H E Ruley
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

4.  Apoptosis mediates and thymidine prevents erythroblast destruction in folate deficiency anemia.

Authors:  M J Koury; D W Horne
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Insulin-like growth factor-binding protein 3 and hemoglobin concentration in older persons living in the community.

Authors:  Francesco Landi; Andrea Russo; Ettore Capoluongo; Matteo Cesari; Rosa Liperoti; Paola Danese; Roberto Bernabei; Graziano Onder
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

6.  A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis.

Authors:  M Z Ratajczak; W I Kuczynski; K Onodera; J Moore; J Ratajczak; D A Kregenow; K DeRiel; A M Gewirtz
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 7.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

Review 8.  Inadequate erythropoietin response to anemia: definition and clinical relevance.

Authors:  G Barosi
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

9.  Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells.

Authors:  K Muta; S B Krantz; M C Bondurant; A Wickrema
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells.

Authors:  X Sui; K Tsuji; S Tajima; R Tanaka; K Muraoka; Y Ebihara; K Ikebuchi; K Yasukawa; T Taga; T Kishimoto; T Nakahata
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.